Healthcare - Biotechnology - NASDAQ - US
$ 44.75
-6.07 %
$ 4.13 B
Market Cap
-7.05
P/E
Price Target
Average
134.89%
Revenue Forecast
Estimate
42.82%
EBIT
Estimate
--30.45%
Net Income
Estimate
25.56%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Ultragenyx Pharmaceutical Inc.
Wall Street analysts predict an average 1-year price target for RARE of $105 , with forecasts ranging from a low of $67 to a high of $135 .
RARE Lowest Price Target
Wall Street Target
67 USD
49.72%
RARE Average Price Target
Wall Street Target
105 USD
134.89%
RARE Highest Price Target
Wall Street Target
135 USD
201.68%
REVENUE FORECAST
Revenue Forecast Chart RARE
EBIT FORECAST
EBIT Forecast Chart RARE
NET INCOME FORECAST
Net Income Chart RARE